ClinicalTrials.Veeva

Menu

Diaphragm Ultrasound in Neuromuscular Disorders

C

Centre d'Investigation Clinique et Technologique 805

Status

Unknown

Conditions

Muscular Dystrophies

Study type

Observational

Funder types

Other

Identifiers

NCT04045158
DIAPH-NMD

Details and patient eligibility

About

Muscular dystrophies are neurologic disease with higher morbidity and mortality. Cardiac function and respiratory muscles can be affected, in addition with skeletal muscle deficiency . Lung function is classically assessed with functionnal pulmonary tests (FPT) . Ultrasound recently emerged as a non-invasive tool to assess diaphragm function.

The aims of the study are:

  • to provide the spectrum of diaphragm ultrasound in patients with muscular dystrophies
  • to assess the correlation between diaphragm ultrasound and FPT
  • to assess the correlation between diaphragm ultrasound and cardiac function

Enrollment

1,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Duchenne muscular dystrophy,
  • Becker muscular dystrophy,
  • LGMD,
  • myotonic dystrophy type 1 and type 2,
  • metabolic myopathy,
  • mitochondrial myopathy,
  • FSHD1 and 2,
  • myasthenia

Exclusion criteria

  • history of cardiac surgery
  • history of thoracic surgery
  • brain traumatism

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems